Suntrust Banks’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $86K | Sell |
12,527
-1,382
| -10% | -$9.49K | ﹤0.01% | 1300 |
|
|
2019
Q2 | $128K | Buy |
13,909
+2,717
| +24% | +$25K | ﹤0.01% | 1277 |
|
|
2019
Q1 | $176K | Buy |
+11,192
| New | +$176K | ﹤0.01% | 1230 |
|
|
2018
Q3 | – | Sell |
-10,521
| Closed | -$256K | – | 1301 |
|
|
2018
Q2 | $256K | Buy |
+10,521
| New | +$256K | ﹤0.01% | 1135 |
|
|
2017
Q3 | – | Sell |
-10,458
| Closed | -$348K | – | 1314 |
|
|
2017
Q2 | $348K | Sell |
10,458
-940
| -8% | -$31.3K | ﹤0.01% | 984 |
|
|
2017
Q1 | $366K | Sell |
11,398
-1,158
| -9% | -$37.2K | ﹤0.01% | 950 |
|
|
2016
Q4 | $452K | Sell |
12,556
-1,635
| -12% | -$58.9K | ﹤0.01% | 1042 |
|
|
2016
Q3 | $651K | Buy |
14,191
+714
| +5% | +$32.8K | ﹤0.01% | 871 |
|
|
2016
Q2 | $676K | Buy |
13,477
+1,131
| +9% | +$56.7K | ﹤0.01% | 840 |
|
|
2016
Q1 | $659K | Sell |
12,346
-121
| -1% | -$6.46K | ﹤0.01% | 828 |
|
|
2015
Q4 | $817K | Sell |
12,467
-422
| -3% | -$27.7K | 0.01% | 777 |
|
|
2015
Q3 | $726K | Buy |
12,889
+493
| +4% | +$27.8K | ﹤0.01% | 734 |
|
|
2015
Q2 | $731K | Buy |
12,396
+1,705
| +16% | +$101K | ﹤0.01% | 739 |
|
|
2015
Q1 | $665K | Sell |
10,691
-395
| -4% | -$24.6K | ﹤0.01% | 736 |
|
|
2014
Q4 | $636K | Sell |
11,086
-40,065
| -78% | -$2.3M | ﹤0.01% | 737 |
|
|
2014
Q3 | $2.75M | Sell |
51,151
-2,348
| -4% | -$126K | 0.02% | 361 |
|
|
2014
Q2 | $2.8M | Sell |
53,499
-16,946
| -24% | -$888K | 0.02% | 372 |
|
|
2014
Q1 | $3.72M | Sell |
70,445
-9,861
| -12% | -$521K | 0.01% | 515 |
|
|
2013
Q4 | $3.22M | Sell |
80,306
-84,534
| -51% | -$3.39M | 0.01% | 543 |
|
|
2013
Q3 | $6.23M | Sell |
164,840
-53,005
| -24% | -$2M | 0.02% | 408 |
|
|
2013
Q2 | $8.54M | Buy |
+217,845
| New | +$8.54M | 0.04% | 366 |
|